Reported Q: Q3 2024 Rev YoY: +5.4% EPS YoY: +32.5% Move: -4.09%
Alcon Inc
0A0D.L
CHF62.65 -4.09%
Exchange LSE Sector Healthcare Industry Medical Instruments Supplies
Q3 2024
Published: Sep 30, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for 0A0D.L

Reported

Report Date

Sep 30, 2024

Quarter Q3 2024

Revenue

2.45B

YoY: +5.4%

EPS

0.53

YoY: +32.5%

Market Move

-4.09%

Previous quarter: Q2 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $2.45B up 5.4% year-over-year
  • EPS of $0.53 increased by 32.5% from previous year
  • Gross margin of 55.9%
  • Net income of 263.00M
  • "" -
0A0D.L
Company 0A0D.L

Swipe to view all report sections

Executive Summary

Alcon Inc. delivered a solid QQ3 2024 performance with resilience in top-line growth and meaningful margin expansion, underpinned by strong operating cash flow. Revenue totaled $2.454 billion, up 5.37% year-over-year (YoY) but down 1.68% quarter-over-quarter (QoQ), reflecting typical seasonality and product mix dynamics in a capital-intensive medical devices company. The company posted a gross profit of $1.371 billion and a gross margin of 55.87%, contributing to an EBITDA of $620 million and an EBITDA margin of 25.26%. Operating income reached $332 million with an operating margin of 13.53%, supporting a net income of $263 million (net margin 10.72%) and earnings per share (EPS) of $0.53, both of which rose meaningfully versus the prior-year period.

Key Performance Indicators

Revenue
Increasing
2.45B
QoQ: -1.68% | YoY: 5.37%
Gross Profit
Increasing
1.37B
55.87% margin
QoQ: -0.22% | YoY: 6.36%
Operating Income
Increasing
332.00M
QoQ: 4.40% | YoY: 13.31%
Net Income
Increasing
263.00M
QoQ: 17.94% | YoY: 28.92%
EPS
Increasing
0.53
QoQ: 17.78% | YoY: 32.50%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 2,596.00 0.35 +4.0% View
Q1 2025 2,473.00 0.70 +0.6% View
Q4 2024 2,502.00 0.57 +1.0% View
Q3 2024 2,454.00 0.53 +5.4% View
Q2 2024 2,496.00 0.45 +3.1% View